| Date | Action | Conf | Host / episode | Summary | 7d | 30d | 90d |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | MENTIONED | LOW | Rob Black Show Afternoon podcast 9-8-26 |
Amgen was the weakest S&P 500 component, down 10%, as Novartis trial setbacks weighed on related names. [audio] | -4.5% | — | — |
| 2026-08-18 | MENTIONED | HIGH | Rob Black Show Afternoon podcast 8-18-26 |
Amgen rose 1.4% to an all-time high. [audio] | +4.6% | -10.2% | — |
| 2026-08-05 | BUY | MEDIUM | Rob Black Show Afternoon podcast 8-5-26 |
Amgen rallied after posting stronger-than-expected earnings. [audio] | +2.0% | +7.8% | — |
| 2026-06-29 | MENTIONED | LOW | Rob Black Show Investors Weighed Pause In Iran Hostilities |
Amgen is mentioned as one of the Dow's heaviest weighted stocks. [audio] | +1.6% | +7.5% | +15.7% |
| 2026-06-04 | MENTIONED | LOW | Rob Black Show Afternoon podcast 6-4-26 |
Amgen mentioned as a company interested in quantum computing for drug discovery. [audio] | +2.4% | +8.3% | +28.9% |